AIP
PRNB

Ameritas Investment Partners’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Ameritas Investment Partners’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,598
Closed -$155K – 3103
2020
Q2 		$155K Buy
2,598
+1,017
+64% +$62.8K 0.01% 1145
2020
Q1 		$94K Hold
1,581
– – 0.01% 1311
2019
Q4 		$87K Buy
1,581
+419
+36% +$15.6K ﹤0.01% 1602
2019
Q3 		$33K Hold
1,162
– – ﹤0.01% 2127
2019
Q2 		$39K Buy
1,162
+687
+145% +$21.4K ﹤0.01% 2058
2019
Q1 		$16K Hold
475
– – ﹤0.01% 2506
2018
Q4 		$13K Buy
+475
New +$12.2K ﹤0.01% 2579

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Ameritas Investment Partners's PRNB Position: Q3 2020 in Review

Ameritas Investment Partners sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 2,598 shares — an estimated $155K sold.

Ameritas Investment Partners first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $155K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Ameritas Investment Partners reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,598 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $155K.
  • Ameritas Investment Partners first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • Ameritas Investment Partners's Principia Biopharma Inc. Common Stock position peaked at $155K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.